跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLABIZA - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
CLABIZA
Approved
STANDARD
CLABIZA
Laboratorio Reig Jofre S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
082aada11fcb8ec7
Company
Laboratorio Reig Jofre S.A.
Type
Standard
Approval Details
Approval Id
082aada11fcb8ec7
Drug Approval Philippines Name
CLABIZA
Product Name
CLABIZA
Registration Number
DRP-5861
Brand Name
CLABIZA
Generic Name
C0-AMOXICLAV
Dosage Form
Powder For Injection (Iv)
Dosage Strength
1.2g
Manufacturer
Laboratorio Reig Jofre S.A.
Importer
Penta Labs Australia (Philippines)
Distributor
Penta Labs Australia (Philippines)
Issuance Date
25 May 2025
Expiry Date
01 June 2031
Pharmacologic Category
Antibacterial (Penicillin- Beta-Lactamase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
082aada11fcb8ec7
Type
Standard
Back to Philippines FDA Approvals